Navigation Links
Phase III Trial of Novartis Drug Afinitor® Met Primary Endpoint of Reducing SEGA Tumor Size in Patients With Tuberous Sclerosis
Date:7/7/2011

octor decide how much Afinitor they need to take.

Afinitor may affect the way other medicines work, and other medicines can affect how Afinitor works. Using Afinitor with other medicines can cause serious side effects. Patients should tell their healthcare provider about all of the medicines they take, including prescription and non-prescription medicines, vitamins and herbal supplements such as: St. John's Wort, and medicine for fungal infections, bacterial infections, tuberculosis, seizures, HIV-AIDS, heart conditions or high blood pressure and medicines that suppress their immune system. Patients should not drink grapefruit juice or eat grapefruit during their treatment with Afinitor as it may make the amount of Afinitor in their blood increase to a harmful level.

Patients should not take Afinitor tablets which are broken or crushed. Patients should not chew or crush the tablets.

The amount of Afinitor in the blood was increased in patients who had liver problems.  Patients should tell their healthcare provider about all their medical conditions, including if they have or have had liver problems, diabetes or high blood sugar, high cholesterol levels, infections, hepatitis B or other medical conditions.

Patients should tell their healthcare provider if they are scheduled to receive any vaccinations. Patients should not receive a live vaccine or be around people who have recently received a live vaccine during treatment with Afinitor.

It is not known if Afinitor will harm an unborn baby. Women should use effective birth control while using Afinitor and for eight weeks after stopping treatment.

Common side effects of Afinitor in patients with advanced pancreatic neuroendocrine tumors include mouth ulcers, rash, diarrhea, swelling of arms, hands, feet, ankles, face or other parts of the body, abdominal pain, nausea, fever and headache. Common side effects of Afinitor in patients with advanced kidney cancer include mouth
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. Ampio Pharmaceuticals Announces Treatment of First Patient in Phase 1b Ampion-In -Knee (AIK) Trial for Osteoarthritis in Australia
2. GlaxoSmithKline Implements Next Phase of New Incentive Compensation Program for U.S. Sales Representatives
3. Ataluren Phase 2 Data in Nonsense Mutation Cystic Fibrosis Published in the European Respiratory Journal
4. Endo Announces Topline Results From Phase 2 Study of Axomadol in Chronic Low Back Pain
5. Phase III Study Shows Once-Daily NVA237 is Superior to Placebo and Similar to Tiotropium in Improving Lung Function in COPD
6. DNA Medicine Institute Awarded Two Phase III SBIR NASA Contracts for Its rHEALTH Sensor
7. Phase I of the Swedish/Issaquah Medical Center Campus to Open in July
8. The Lancet Publishes Data from Protege, MacroGenics Phase 3 Clinical Study of Teplizumab in Type 1 Diabetes Patients
9. Morphotek®, Inc. Announces Initiation of Farletuzumab Phase II Study in First-Line Treatment of Non-Small Cell Lung Cancer
10. Palatin Technologies, Inc. Initiates Enrollment in Phase 2b Trial With Bremelanotide in Women With Female Sexual Dysfunction
11. Cardium Announces Plans to Acquire Transdel Pharmaceuticals Phase 3 Topical Analgesic and Cosmeceutical Business Assets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... AUSTIN, Texas , March 30, 2015 ... highlight the My Diabetes Emergency Plan at the 2015 ... encourage you to be prepared to manage your #diabetes ... of Endocrinology (ACE) – the charitable, educational and scientific ... – has joined forces with Lilly Diabetes to share ...
(Date:3/30/2015)... , March 30, 2015  Check-Cap Ltd. (NASDAQ: ... focused on the development of a preparation-free ingestible imaging ... colorectal cancer, announced today that its CEO, Guy Neev ... 31, 2015 trading day.  Neev and Check-Cap will participate ... the company,s initial public offering and simultaneous private placement ...
(Date:3/30/2015)... March 30, 2015  Uroplasty, Inc. (NASDAQ: UPI ... shareholders have voted at the special meeting of ... previously announced agreement and plan of merger between ... with the outcome of today,s special meetings, and ... for approving the merger agreement," said Rob ...
Breaking Medicine Technology:Preparation Is Personal for Those with Chronic Illnesses 2Preparation Is Personal for Those with Chronic Illnesses 3Preparation Is Personal for Those with Chronic Illnesses 4Check-Cap to Celebrate Initial Public Offering with NASDAQ Closing Bell Ceremony on March 31, 2015 2Check-Cap to Celebrate Initial Public Offering with NASDAQ Closing Bell Ceremony on March 31, 2015 3Uroplasty and Vision-Sciences Shareholders Approve Merger Agreement 2Uroplasty and Vision-Sciences Shareholders Approve Merger Agreement 3Uroplasty and Vision-Sciences Shareholders Approve Merger Agreement 4
... Pa., May 25, 2011 A study titled ... published in the May 26 issue of ... prostate cancer who have received prior chemotherapy containing ... when treated with ZYTIGA ™ (abiraterone acetate) ...
... (NASDAQ: ITMN ) will outline the company,s corporate ... ongoing plans to commercialize Esbriet ® (pirfenidone) in Europe, ... pirfenidone study, during a meeting with analysts in New York ... the presentations beginning at 8:30 a.m. EDT.   ...
Cached Medicine Technology:Pivotal Phase 3 Study Published in The New England Journal of Medicine (NEJM) Finds Overall Survival of Patients with Metastatic Castration-Resistant Prostate Cancer is Significantly Improved with ZYTIGA™ (abiraterone acetate) 2Pivotal Phase 3 Study Published in The New England Journal of Medicine (NEJM) Finds Overall Survival of Patients with Metastatic Castration-Resistant Prostate Cancer is Significantly Improved with ZYTIGA™ (abiraterone acetate) 3Pivotal Phase 3 Study Published in The New England Journal of Medicine (NEJM) Finds Overall Survival of Patients with Metastatic Castration-Resistant Prostate Cancer is Significantly Improved with ZYTIGA™ (abiraterone acetate) 4Pivotal Phase 3 Study Published in The New England Journal of Medicine (NEJM) Finds Overall Survival of Patients with Metastatic Castration-Resistant Prostate Cancer is Significantly Improved with ZYTIGA™ (abiraterone acetate) 5Pivotal Phase 3 Study Published in The New England Journal of Medicine (NEJM) Finds Overall Survival of Patients with Metastatic Castration-Resistant Prostate Cancer is Significantly Improved with ZYTIGA™ (abiraterone acetate) 6InterMune to Provide Overview of Corporate Strategy, Update on Esbriet Commercialization Plans in the EU and Details of Phase 3 ASCEND Study 2InterMune to Provide Overview of Corporate Strategy, Update on Esbriet Commercialization Plans in the EU and Details of Phase 3 ASCEND Study 3InterMune to Provide Overview of Corporate Strategy, Update on Esbriet Commercialization Plans in the EU and Details of Phase 3 ASCEND Study 4InterMune to Provide Overview of Corporate Strategy, Update on Esbriet Commercialization Plans in the EU and Details of Phase 3 ASCEND Study 5InterMune to Provide Overview of Corporate Strategy, Update on Esbriet Commercialization Plans in the EU and Details of Phase 3 ASCEND Study 6
(Date:3/30/2015)... Dr. Jeffrey Allred DDS, with his practice ... second opinion consultations for patients who need a ... dental second opinions show how small percentage of dentistry patients ... Only 6%” – says Dr. Allred. , “People should ... trusting the dental care provider, for the simple fact that ...
(Date:3/30/2015)... Birmingham, AL (PRWEB) March 30, 2015 ... medical malpractice and defective medical devices, has filed a ... Alabama family whose baby died following his premature birth ... Mobile County Circuit Court, alleges that the Mirena IUD ... strings, which also made the device difficult to remove. ...
(Date:3/30/2015)... 30, 2015 “ iCareTech ” was featured ... takes a look at the latest and coolest technology products ... reporter and technology expert, conducted the review and shared with ... dedicated to the medical and health fields. , Wearable technology ... over the past couple of years. Well, at CES, NewsWatch ...
(Date:3/30/2015)... According to a recently published report by iData ... continue to dominate the European soft tissue reinforcement and ... numbers of ventral hernias, and the adoption of expensive ... market share represented by ventral hernia repair devices is ... growing use of expensive biologics,” explains Dr. Kamran Zamanian, ...
(Date:3/30/2015)... March 30, 2015 Follow us ... efforts to develop and establish chronic pain rehabilitation centers ... in the market is poised to benefit from the ... of the increase in chronic health conditions such as ... arthritis, among others. While conventional treatment for pain management ...
Breaking Medicine News(10 mins):Health News:Allred Dental Offers Complimentary 15 Minute Consults with Dr. Jeffrey Allred in San Marcos, CA 2Health News:Mirena Lawsuit Filed By Southern Med Law Seeks Compensation For Purported Wrongful Death Following Premature Birth Of Infant 2Health News:Mirena Lawsuit Filed By Southern Med Law Seeks Compensation For Purported Wrongful Death Following Premature Birth Of Infant 3Health News:Mirena Lawsuit Filed By Southern Med Law Seeks Compensation For Purported Wrongful Death Following Premature Birth Of Infant 4Health News:World’s First Medical Intelligent Band was Featured on NewsWatch Television on January 30, 2015 2Health News:High Prices for Advanced Biologic Hernia Repair Technology Driving European Soft Tissue Reinforcement and Regeneration Market Growth 2Health News:High Prices for Advanced Biologic Hernia Repair Technology Driving European Soft Tissue Reinforcement and Regeneration Market Growth 3Health News:Technological Developments, Better Patient Awareness & Affordability Drive the Pain Management Devices Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Technological Developments, Better Patient Awareness & Affordability Drive the Pain Management Devices Market, According to a New Report by Global Industry Analysts, Inc. 3
... 19 Statement by Chris,Cathcart, President, CSPA: "The ... report issued by the Natural Resources,Defense Council (NRDC) ... air,freshener products. NRDC,s report appears to be based ... each of 14 air freshener products. As a,result, ...
... September, 2007 The decline in cervical ... there are reasons to be optimistic about even further ... women who are not screened. A meta-analysis by Spence ... Preventive Medicine shows that undergoing Pap smears irregularly or ...
... University School of Medicine (BUSM), Boston University School ... Lung and Blood Institute (NHLBI), have completed analyses ... two generations of participants from the landmark Framingham ... genetic differences that potentially affect the risk for ...
... peripheral artery disease , , WEDNESDAY, Sept. 19 (HealthDay ... tickling America,s funny bone and tugging at its ... working for now, crisscrossing the country to raise ... cardiovascular threat called peripheral artery disease (PAD). , ...
... Reserve Grand Champion Pair Of Cattle Comes From Binson,s ... Home Health Care Centers, Donation Of Food And Funds Continues Longstanding ... ... homeless and working poor will be among those to benefit from a,generous gift from Binson,s ...
... to end insurance ... pass S.558, ALEXANDRIA, Va., Sept. 18 Mental ... legislation,today to end mental health insurance discrimination, and its ... Edward,Kennedy (D-Mass.) for their leadership. The bill -- S. ...
Cached Medicine News:Health News:Consumer Specialty Products Association Highly Critical of NRDC Study on Home Air Fresheners 2Health News:Cervical cancer screening: Too many are left unprotected 2Health News:Researchers provide genetic associations from a genome-wide scan for cardiovascular disease traits 2Health News:Researchers provide genetic associations from a genome-wide scan for cardiovascular disease traits 3Health News:'Cosby' Star Tackles a Silent Heart Threat 2Health News:'Cosby' Star Tackles a Silent Heart Threat 3Health News:'Cosby' Star Tackles a Silent Heart Threat 4Health News:$8,000 Winning Bids at Governor's Livestock Auction to Benefit College-Bound Youth and Homeless 2Health News:Senate Passes 'Mental Health Parity' 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: